Karl P. Flora
- Virology top 5%
- Occupational Therapy top 5%
- Safe Handling of Antineoplastic Drugs 4
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 3
- Toxicology top 5%
- Forensic Toxicology and Drug Analysis 3
- Pharmacology top 10%
- Cannabis and Cannabinoid Research 4
- Pharmacy and Medical Practices 3
-
- Pharmaceutical studies and practices 7
-
- Cancer Treatment and Pharmacology 5
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Lawrence A. TrisselJames C. CradockJonathan WilsonB. Rao VishnuvajjalaBarry R. GoldspielJonathan D. AdamsSusan G. ArbuckRichard W. Finley
- Partner nations
- United StatesMalaysiaNetherlands
In The Last Decade
Karl P. Flora
26 papers receiving 858 citations
Peers
Comparison fields: 5 of 106
- Virology 154
- Occupational Therapy 49
- Infectious Diseases 209
- Toxicology 35
- Pharmacology 136
Countries citing papers authored by Karl P. Flora
This map shows the geographic impact of Karl P. Flora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl P. Flora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl P. Flora more than expected).
Fields of papers citing papers by Karl P. Flora
This network shows the impact of papers produced by Karl P. Flora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl P. Flora. The network helps show where Karl P. Flora may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl P. Flora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 36 | |
| 2 | 1996 | 28 | |
| 3 | 1995 | 20 | |
| 4 | 1994 | 17 | |
| 5 | 1994 | 59 | |
| 6 | Taxol: a history of pharmaceutical development and current pharmaceutical concerns. | 1993 | 136 |
| 7 | 1991 | 45 | |
| 8 | 1990 | 12 | |
| 9 | 1990 | 12 | |
| 10 | 1988 | 37 | |
| 11 | 1987 | 127 | |
| 12 | 1986 | 71 | |
| 13 | 1985 | 23 | |
| 14 | 1984 | 12 | |
| 15 | 1984 | 6 | |
| 16 | 1984 | 15 | |
| 17 | 1982 | 10 | |
| 18 | 1982 | 11 | |
| 19 | 1981 | 5 | |
| 20 | Stability of anthracycline antitumor agents in four infusion fluids. | 1981 | 25 |
About Karl P. Flora
Karl P. Flora is a scholar working on Toxicology, Occupational Therapy and Geriatrics and Gerontology, having authored 26 papers that have together received 897 indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (7 papers), Cancer Treatment and Pharmacology (5 papers), Cancer therapeutics and mechanisms (5 papers), Safe Handling of Antineoplastic Drugs (4 papers), Cannabis and Cannabinoid Research (4 papers), Pharmacy and Medical Practices (3 papers), HIV/AIDS drug development and treatment (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). The work is most often cited by research in Virology (154 citations), Occupational Therapy (49 citations) and Infectious Diseases (209 citations). Karl P. Flora has collaborated with scholars based in United States, Malaysia and Netherlands. Frequent co-authors include Lawrence A. Trissel, James C. Cradock, Jonathan Wilson, B. Rao Vishnuvajjala, Barry R. Goldspiel, Jonathan D. Adams, Susan G. Arbuck, Richard W. Finley, Hiroaki Mitsuya and David G. Johns.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.